Thyrocare Technologies
THYROCARE · Healthcare > Hospital & Healthcare Services · Chairman: A Velumani · MD: Dharmil Sheth · Listing date: May 10, 2016 · Employees: 1582 · Navi Mumbai · http://www.thyrocare.com

Stock Price vs Company Growth
1d
0.1%
1w
6.2%
1m
10.0%
3m
54.1%
6m
25.7%
1y
70.8%
5y
17.7%
all
8.4%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,083 0.1%
680
1,107
Company Overview

Sales
687 Cr
Growth: 15.4%
Profit after Tax
91.6 Cr
Growth: 4.5%
Small Cap
5,740 Cr
P/E: 62.9x
Industry P/E: 50.5x
Fundamentals

Sales (Cr) ₹ 687
Growth 15.4%
EBITDA 27.7%
P/S 8.4x
Dividend 2.0%
P/E 62.9x
Book Value ₹ 103
PEG Ratio 4.1x
ROE 16.1%
P/B 10.5x
Shareholding Pattern

Institutions
Arisaig Asia Consumer Fund Limited
6.11 %
Nippon Life India Trustee Ltd-A/C Nippon India Nifty Small Cap 250 Index Fund
3.57 %
Fundsmith Emerging Equities Trust Plc
1.46 %
Promoters
Dr.A.Velumani
28.02 %
Thyrocare Publications Llp
12.36 %
Thyrocare Properties And Infrastructure Private Imited
9.88 %
A.Sundararaju Huf
4.57 %
Sumathi Infra Project Llp
2.98 %
Others
Bakak Financial Securities
2.84 %
Llp
0.13 %
Increase    Decrease    No change
Company Profile Detailed

Thyrocare Technologies is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia.
Investors (82)
Followers (23)